N/A

Torres, T., Chiricozzi, A., Puig, L., Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”, <<AMERICAN JOURNAL OF CLINICAL DERMATOLOGY>>, 2021; 22 (6): 903-904. [doi:10.1007/s40257-021-00640-5] [http://hdl.handle.net/10807/199640]

Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”

Chiricozzi, A.;
2021

Abstract

N/A
Inglese
Torres, T., Chiricozzi, A., Puig, L., Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”, <<AMERICAN JOURNAL OF CLINICAL DERMATOLOGY>>, 2021; 22 (6): 903-904. [doi:10.1007/s40257-021-00640-5] [http://hdl.handle.net/10807/199640]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/199640
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact